8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze

Psychopharmacology

Volumn 153, Issue 3, 2001, Pages 365-372

  Koks S ^a   Beljajev, S ^a   Koovit, I ^a   Abramov, U ^a   Bourin, Michel ^b   Vasar, Eero ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

5 hydroxytryptamine; 8 OH DPAT; Anxiety; Deramciclane; Elevated plus maze; Handling adaptation; Locomotor activity; Paroxetine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DERAMCICLANE FUMARATE; PAROXETINE; SEROTONIN 2A ANTAGONIST;

ADAPTATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; BORNANES; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; PAROXETINE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035146780     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000594     Document Type: Article

References (25)

1. 1A receptor antagonist, WAY 100,635, in the rat
2. Involvement of serotonin receptor subtypes in panic disorder
3. 1A-receptor ligands in dorsal raphe and ventral hippocampus
4. Novel environment and cat odor change GABA and 5-HT release and uptake in the rat
5. 1A receptor modulation of anxiety in two ethological animal tests
6. 1A receptor antagonists: Utility as research tools and therapeutic agents
7. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
8. Receptor binding profile and anxiolytic activity of deramciclane (EGIS-3886) in animal models
9. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine
10. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat
11. 5-HT drugs in animal models of anxiety
12. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour
13. Multiple serotonin mechanisms in animal models of anxiety: Environmental, emotional and cognitive factors
14. 5-HT and anxiety
15. 1C receptor antagonists
16. Ultrastructural localization of 5-hydroxytrypramine 1A receptors in the rat brain
17. Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor
18. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
19. A comparison of the behavioural effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP
20. 1A receptor in the brain: Correlation with receptor binding
21. Effects of BOC-CCK-4 and L-365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze
22. Animal models of anxiety: An ethological perspective
23. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
24. The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test
25. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze